These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 9931283

  • 1. Effects of the antiestrogenic environmental pollutant 3,3',4,4', 5-pentachlorobiphenyl (PCB #126) in rat bone and uterus: diverging effects in ovariectomized and intact animals.
    Lind PM, Eriksen EF, Sahlin L, Edlund M, Orberg J.
    Toxicol Appl Pharmacol; 1999 Feb 01; 154(3):236-44. PubMed ID: 9931283
    [Abstract] [Full Text] [Related]

  • 2. Estrogen supplementation modulates effects of the endocrine disrupting pollutant PCB126 in rat bone and uterus: diverging effects in ovariectomized and intact animals.
    Lind PM, Eriksen EF, Lind L, Orberg J, Sahlin L.
    Toxicology; 2004 Jul 01; 199(2-3):129-36. PubMed ID: 15147787
    [Abstract] [Full Text] [Related]

  • 3. The dioxin-like pollutant PCB 126 (3,3',4,4',5-pentachlorobiphenyl) affects risk factors for cardiovascular disease in female rats.
    Lind PM, Orberg J, Edlund UB, Sjöblom L, Lind L.
    Toxicol Lett; 2004 May 02; 150(3):293-9. PubMed ID: 15110081
    [Abstract] [Full Text] [Related]

  • 4. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program.
    Natl Toxicol Program Tech Rep Ser; 2006 Jan 02; (520):4-246. PubMed ID: 16628245
    [Abstract] [Full Text] [Related]

  • 5. Change of bone tissue composition and impaired bone strength in rats exposed to 3,3',4,4',5-pentachlorobiphenyl (PCB126).
    Lind PM, Larsson S, Oxlund H, Hâkansson H, Nyberg K, Eklund T, Orberg J.
    Toxicology; 2000 Sep 07; 150(1-3):41-51. PubMed ID: 10996662
    [Abstract] [Full Text] [Related]

  • 6. Effects of tibolone on the development of osteopenia induced by ovariectomy in rats.
    Pytlik M.
    Pol J Pharmacol; 2002 Sep 07; 54(1):35-43. PubMed ID: 12020042
    [Abstract] [Full Text] [Related]

  • 7. Tanshinone prevents cancellous bone loss induced by ovariectomy in rats.
    Cui L, Wu T, Liu YY, Deng YF, Ai CM, Chen HQ.
    Acta Pharmacol Sin; 2004 May 07; 25(5):678-84. PubMed ID: 15132837
    [Abstract] [Full Text] [Related]

  • 8. Comparison of tamoxifen effects on the actions of triiodothyronine or growth hormone in the ovariectomized-hypothyroid rat.
    Fitts JM, Klein RM, Powers CA.
    J Pharmacol Exp Ther; 1998 Jul 07; 286(1):392-402. PubMed ID: 9655884
    [Abstract] [Full Text] [Related]

  • 9. Advantages of raloxifene over alendronate or estrogen on nonreproductive and reproductive tissues in the long-term dosing of ovariectomized rats.
    Sato M, Bryant HU, Iversen P, Helterbrand J, Smietana F, Bemis K, Higgs R, Turner CH, Owan I, Takano Y, Burr DB.
    J Pharmacol Exp Ther; 1996 Oct 07; 279(1):298-305. PubMed ID: 8859007
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of tamoxifen and fluoride on bone mineral density, biomechanical properties and blood lipids in ovariectomized rats.
    Czerny B, Pawlik A, Juzyszyn Z, Myśliwiec Z.
    Basic Clin Pharmacol Toxicol; 2004 Oct 07; 95(4):162-5. PubMed ID: 15504151
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the pharmacologic profile of a standardized soy extract in the ovariectomized rat model of menopause: effects on bone, uterus, and lipid profile.
    Gallo D, Zannoni GF, Apollonio P, Martinelli E, Ferlini C, Passetti G, Riva A, Morazzoni P, Bombardelli E, Scambia G.
    Menopause; 2005 Oct 07; 12(5):589-600. PubMed ID: 16145313
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Longitudinal and cross-sectional analysis of raloxifene effects on tibiae from ovariectomized aged rats.
    Sato M, Kim J, Short LL, Slemenda CW, Bryant HU.
    J Pharmacol Exp Ther; 1995 Mar 07; 272(3):1252-9. PubMed ID: 7891341
    [Abstract] [Full Text] [Related]

  • 15. Dose effects of propranolol on cancellous and cortical bone in ovariectomized adult rats.
    Bonnet N, Laroche N, Vico L, Dolleans E, Benhamou CL, Courteix D.
    J Pharmacol Exp Ther; 2006 Sep 07; 318(3):1118-27. PubMed ID: 16740619
    [Abstract] [Full Text] [Related]

  • 16. Effects on bone tissue in ewes (Ovies aries) and their foetuses exposed to PCB 118 and PCB 153.
    Gutleb AC, Arvidsson D, Orberg J, Larsson S, Skaare JU, Aleksandersen M, Ropstad E, Lind PM.
    Toxicol Lett; 2010 Feb 01; 192(2):126-33. PubMed ID: 19850115
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J, Miller MA, Newman MK, Metcalfe AF, Turner CH, Recker RR, Smith SY.
    Calcif Tissue Int; 2006 Oct 01; 79(4):262-72. PubMed ID: 16969596
    [Abstract] [Full Text] [Related]

  • 19. Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.
    Uyar Y, Baytur Y, Inceboz U, Demir BC, Gumuser G, Ozbilgin K.
    Maturitas; 2009 Jul 20; 63(3):261-7. PubMed ID: 19386450
    [Abstract] [Full Text] [Related]

  • 20. Effects of the selective estrogen receptor modulator ospemifene on bone in rats.
    Kangas L, Härkönen P, Väänänen K, Peng Z.
    Horm Metab Res; 2014 Jan 20; 46(1):27-35. PubMed ID: 24108389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.